Loading company…
Waltham-based biopharmaceutical developer working on drugs for unmet medical needs, with a focus on oncology and metabolic disorders.
Founded in 2015 and based in Waltham, US, Pyramid Biosciences Inc. develops biopharmaceutical products for unmet medical needs using a proprietary drug discovery platform. Its target areas include oncology and metabolic disorders, and its clients are research institutions and pharmaceutical companies in North America and Europe. Revenue comes from B2B collaborations, including milestone payments and royalties. The company raised USD 33.54 mn in a Series B round in October 2021, led by Oracle Investment Management, Inc. Brian Lestini is CEO, and Kollol Pal is also named.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in